Keywords: Pfizer, Management, Head of medicines development, M&A, King Pharma, Tender offer completed

Pfizer lures GSK exec to head medicines development unit; completes tender offer for King Pharma

Article | 01 February 2011

Print This

The world’s largest drugmaker, Pfizer (NYSE: PFE) revealed that, effective yesterday, Yvonne Greenstreet has become senior vice president ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in